Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data showing that it can improve blood glucose compared to a go-to therapy for type 2 ...

Power Technology has officially launched the world's first automated, high-volume production line in Conklin, New York, to ...

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation and regenerative solutions, announced that it ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved oral semaglutide for primary and secondary prevention of CV events in high-risk adults with ...

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by an additional 2.1% when taken with ...

What Is Rybelsus, and Why Does It Matter? Rybelsus (semaglutide) is a once-daily pill used to help lower blood sugar in adults with type 2 diabetes (T2D). It belongs to a group of medicines called GLP ...

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by an additional 2.1% when taken with ...

After completing her Bachelor's and Master's degrees in the Department of Communication at UB, Tahleen decided that there was no better fit for her than UB to pursue her PhD. Tahleen chose to stay in ...

If your patients are taking GLP-1s, you’ve explained the common side effects, such as gastrointestinal (GI) issues and muscle-loss implications. However, GLP-1 receptor agonists, often prescribed for ...

This is read by an automated voice. Please report any issues or inconsistencies here. The Toronto Blue Jays routed the favored Dodgers 11-4 in Game 1 of the World Series with a historic pinch-hit ...

Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 ...

For the second straight week, you’re seeing the 2025 Boston College Eagles (1-6, 0-4) compared to the 2012 Boston College Eagles (2-10, 1-7). In 2012, Frank Spaziani was in his fourth season as head ...